JP2020510692A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510692A5
JP2020510692A5 JP2019551318A JP2019551318A JP2020510692A5 JP 2020510692 A5 JP2020510692 A5 JP 2020510692A5 JP 2019551318 A JP2019551318 A JP 2019551318A JP 2019551318 A JP2019551318 A JP 2019551318A JP 2020510692 A5 JP2020510692 A5 JP 2020510692A5
Authority
JP
Japan
Prior art keywords
group
formula
polymer
alkyl
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019551318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510692A (ja
JP7355649B2 (ja
Filing date
Publication date
Priority claimed from US15/458,546 external-priority patent/US10113033B2/en
Application filed filed Critical
Priority claimed from PCT/AU2018/050233 external-priority patent/WO2018165710A1/en
Publication of JP2020510692A publication Critical patent/JP2020510692A/ja
Publication of JP2020510692A5 publication Critical patent/JP2020510692A5/ja
Application granted granted Critical
Publication of JP7355649B2 publication Critical patent/JP7355649B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019551318A 2017-03-14 2018-03-14 薬物-ポリマーコンジュゲート Active JP7355649B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15/458,546 2017-03-14
US15/458,546 US10113033B2 (en) 2013-03-08 2017-03-14 Polymer conjugate for delivery of a bioactive agent
AU2017900888A AU2017900888A0 (en) 2017-03-14 Biodegradable drug-polymer conjugate
AU2017900888 2017-03-14
PCT/AU2018/050233 WO2018165710A1 (en) 2017-03-14 2018-03-14 Drug-polymer conjugate

Publications (3)

Publication Number Publication Date
JP2020510692A JP2020510692A (ja) 2020-04-09
JP2020510692A5 true JP2020510692A5 (https=) 2021-04-30
JP7355649B2 JP7355649B2 (ja) 2023-10-03

Family

ID=63521659

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019551318A Active JP7355649B2 (ja) 2017-03-14 2018-03-14 薬物-ポリマーコンジュゲート
JP2019551307A Active JP7204661B2 (ja) 2017-03-14 2018-03-14 生分解性薬物-ポリマーコンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019551307A Active JP7204661B2 (ja) 2017-03-14 2018-03-14 生分解性薬物-ポリマーコンジュゲート

Country Status (14)

Country Link
US (2) US11787906B2 (https=)
EP (2) EP3595670A4 (https=)
JP (2) JP7355649B2 (https=)
KR (2) KR102642432B1 (https=)
CN (4) CN110461336A (https=)
AU (2) AU2018233158B2 (https=)
CA (1) CA3054084A1 (https=)
CL (1) CL2019002600A1 (https=)
IL (2) IL269321B (https=)
MX (2) MX2019010837A (https=)
NZ (2) NZ756626A (https=)
SG (2) SG11201907956UA (https=)
WO (2) WO2018165710A1 (https=)
ZA (2) ZA201905589B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate
MX2019010837A (es) * 2017-03-14 2019-12-19 Polyactiva Pty Ltd Conjugado biodegradable de farmaco-polimero.
WO2021024041A1 (en) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Controlled release drug dimers
CA3154867A1 (en) * 2019-09-19 2021-03-25 Polyactiva Pty Ltd Biodegradable drug-polymer conjugate
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
WO2024084056A1 (en) * 2022-10-21 2024-04-25 Etherna Immunotherapies Nv Ionizable lipids

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1044797B (it) 1974-10-15 1980-04-21 Ferruti Paolo Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego
JPH03220201A (ja) 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
JP4419368B2 (ja) 2002-07-25 2010-02-24 小野薬品工業株式会社 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤
CA2617907A1 (en) 2005-08-05 2007-02-15 Syntarga B.V. Triazole-containing releasable linkers and conjugates comprising the same
MY155629A (en) 2008-10-10 2015-11-13 Polyactiva Pty Ltd Biodegradable polymer-bioactive moiety conjugates
SI2340271T1 (sl) 2008-10-10 2019-08-30 Polyactiva Pty Ltd. Konjugati polimer-bioaktivnega sredstva
US8535655B2 (en) * 2008-10-10 2013-09-17 Polyactiva Pty Ltd. Biodegradable polymer—bioactive moiety conjugates
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US20120130045A1 (en) 2009-06-01 2012-05-24 Ablitech, Inc. Biomolecule-polymer conjugates and methods of making same
FR2961694B1 (fr) 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
WO2012075117A2 (en) 2010-12-01 2012-06-07 Ablitech, Inc. Small molecule-polymer conjugates and methods of making same
WO2012139164A1 (en) * 2011-04-12 2012-10-18 Polyactiva Pty Ltd Polymer conjugated prostaglandin analogues
JP2013035802A (ja) 2011-08-10 2013-02-21 D Western Therapeutics Institute Inc 緑内障又は高眼圧症の予防又は治療剤
MY190370A (en) * 2012-06-26 2022-04-18 Polyactiva Pty Ltd Polymer-nsaid conjugate
US10113033B2 (en) 2013-03-08 2018-10-30 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
DK2964224T3 (en) * 2013-03-08 2024-10-14 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
MX2019010837A (es) * 2017-03-14 2019-12-19 Polyactiva Pty Ltd Conjugado biodegradable de farmaco-polimero.
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate
US11207417B2 (en) 2017-03-14 2021-12-28 Polyactiva Pty Ltd Drug-polymer conjugate

Similar Documents

Publication Publication Date Title
JP2020510692A5 (https=)
US20200392498A1 (en) Polynucleotide constructs having bioreversible and non-bioreversible groups
AU730244B2 (en) High molecular weight polymer-based prodrugs
Huang et al. A novel kind of antitumour drugs using sulfonamide as parent compound
JP2020510690A5 (https=)
RU2017121906A (ru) Конъюгаты цистеамина и жирной кислоты и их применение в качестве активаторов аутофагии
FI3558390T3 (fi) Amanitinivasta-ainekonjugaatit
JP2022000421A5 (https=)
JP2016515099A5 (https=)
JP2018528261A5 (https=)
JP2018035142A5 (https=)
JP2010527913A5 (https=)
CN107405336A (zh) 作为免疫调节剂的1,3,4‑噁二唑和噻二唑化合物
JP2018516243A5 (https=)
JP2018511628A5 (https=)
JP2013540463A5 (https=)
CA2803556A1 (en) Branched hetero polyethylene glycol and intermediate
RU2012140432A (ru) Аминосодержащие полимеры для применения в качестве секвестрантов желчных кислот
NZ757356A (en) Biodegradable drug-polymer conjugate
CA3119288A1 (en) Hybrid immolative cell-penetrating complexes for nucleic acid delivery
RU2012102774A (ru) Сополимеры, полимерные частицы, содержащие упомянутые сополимеры, и сополимерные связующие для композиций радиационно-чувствительных покрытий для негативных копировальных радиационно-чувствительных литографических печатных форм
US9951179B2 (en) Cyclic carbonate monomers and ring opened polycarbonates therefrom
RU2020132293A (ru) Амидные пролекарства низкомолекулярных модуляторов ядерных рецепторов
JP5019524B2 (ja) 新規ポリ(メタ)アクリレート共重合体ならびに小胞体及びゴルジ体への送達方法
JP2014515354A5 (https=)